Structure

Physi-Chem Properties

Molecular Weight:  438.2
Volume:  443.836
LogP:  3.406
LogD:  2.871
LogS:  -4.927
# Rotatable Bonds:  1
TPSA:  86.11
# H-Bond Aceptor:  6
# H-Bond Donor:  0
# Rings:  6
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.483
Synthetic Accessibility Score:  5.523
Fsp3:  0.654
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.348
MDCK Permeability:  2.046844019787386e-05
Pgp-inhibitor:  0.991
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.671
30% Bioavailability (F30%):  0.97

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.473
Plasma Protein Binding (PPB):  84.52136993408203%
Volume Distribution (VD):  1.838
Pgp-substrate:  15.170578956604004%

ADMET: Metabolism

CYP1A2-inhibitor:  0.029
CYP1A2-substrate:  0.474
CYP2C19-inhibitor:  0.225
CYP2C19-substrate:  0.725
CYP2C9-inhibitor:  0.431
CYP2C9-substrate:  0.026
CYP2D6-inhibitor:  0.142
CYP2D6-substrate:  0.062
CYP3A4-inhibitor:  0.839
CYP3A4-substrate:  0.772

ADMET: Excretion

Clearance (CL):  10.223
Half-life (T1/2):  0.579

ADMET: Toxicity

hERG Blockers:  0.079
Human Hepatotoxicity (H-HT):  0.246
Drug-inuced Liver Injury (DILI):  0.108
AMES Toxicity:  0.038
Rat Oral Acute Toxicity:  0.974
Maximum Recommended Daily Dose:  0.913
Skin Sensitization:  0.145
Carcinogencity:  0.696
Eye Corrosion:  0.007
Eye Irritation:  0.101
Respiratory Toxicity:  0.968

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC60973

Natural Product ID:  NPC60973
Common Name*:   Deacetoxy-7-Oxogedunin
IUPAC Name:   n.a.
Synonyms:   7-Ketogedunin; 7-Oxo-Gedunin; 7-Oxogedunin
Standard InCHIKey:  PMISPNORJONCHB-OASIGRBWSA-N
Standard InCHI:  InChI=1S/C26H30O6/c1-22(2)16-12-18(28)25(5)15(23(16,3)9-7-17(22)27)6-10-24(4)19(14-8-11-30-13-14)31-21(29)20-26(24,25)32-20/h7-9,11,13,15-16,19-20H,6,10,12H2,1-5H3/t15-,16+,19+,20-,23-,24+,25+,26-/m1/s1
SMILES:  CC1(C)[C@@H]2CC(=O)[C@]3(C)[C@H](CC[C@@]4(C)[C@H](c5ccoc5)OC(=O)[C@@H]5[C@]34O5)[C@@]2(C)C=CC1=O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL452232
PubChem CID:   21594780
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001640] Naphthopyrans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota n.a. rind n.a. DOI[10.1002/hlca.200800177]
NPO7664 Pseudocedrela kotschyi Species Meliaceae Eukaryota roots n.a. n.a. PMID[17253841]
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota seeds n.a. n.a. PMID[17323995]
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota n.a. bark n.a. PMID[17450509]
NPO3494 Swietenia mahagoni Species Meliaceae Eukaryota fruits n.a. n.a. PMID[19902967]
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota seed kernels n.a. n.a. PMID[19908853]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[20112995]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[20146503]
NPO4899 Streptomyces fungicidicus Species Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[20353165]
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[20411928]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds Thai n.a. PMID[21733687]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[22724531]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[26114936]
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[31895570]
NPO20413 Meliaceae spp. Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[9134742]
NPO20413 Meliaceae spp. Species Meliaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO10266 Alaria nana Species Alariaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28813 Xylocarpus granatum Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3494 Swietenia mahagoni Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7417 Pieris melete Species Pieridae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO9736 Artemisia arctica Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO1469 Cyperus compressus Species Cyperaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO8937 Ferreirea spectabilis n.a. n.a. n.a. n.a. n.a. n.a. Database[UNPD]
NPO7664 Pseudocedrela kotschyi Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO4899 Streptomyces fungicidicus Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT839 Cell Line L6 Rattus norvegicus IC50 > 90.0 ug.mL-1 PMID[496710]
NPT91 Cell Line KB Homo sapiens Activity = 99.0 % PMID[496711]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 16170.0 nM PMID[496715]
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 22800.0 nM PMID[496716]
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 16680.0 nM PMID[496716]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 1.775 ug.mL-1 PMID[496710]
NPT633 Organism Leishmania donovani Leishmania donovani IC50 = 0.994 ug.mL-1 PMID[496710]
NPT844 Organism Trypanosoma brucei rhodesiense Trypanosoma brucei rhodesiense IC50 = 3.4 ug.mL-1 PMID[496710]
NPT580 Organism Trypanosoma cruzi Trypanosoma cruzi IC50 > 30.0 ug.mL-1 PMID[496710]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 > 10.0 ug.mL-1 PMID[496711]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity < 0.39 % PMID[496711]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity < 0.0005 % PMID[496711]
NPT72 Individual Protein Solute carrier organic anion transporter family member 1B3 Homo sapiens Inhibition = 85.14 % PMID[496717]
NPT73 Individual Protein Solute carrier organic anion transporter family member 1B1 Homo sapiens Inhibition = 40.28 % PMID[496717]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC60973 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9732 High Similarity NPC263265
0.9732 High Similarity NPC209364
0.9669 High Similarity NPC305016
0.9667 High Similarity NPC286722
0.9605 High Similarity NPC470939
0.9603 High Similarity NPC475295
0.9603 High Similarity NPC473473
0.9603 High Similarity NPC237155
0.96 High Similarity NPC107646
0.9539 High Similarity NPC25255
0.9536 High Similarity NPC472283
0.9484 High Similarity NPC473753
0.9484 High Similarity NPC473766
0.9477 High Similarity NPC193798
0.9477 High Similarity NPC5079
0.9474 High Similarity NPC473368
0.9416 High Similarity NPC234660
0.9416 High Similarity NPC51568
0.9412 High Similarity NPC475381
0.9404 High Similarity NPC469850
0.9359 High Similarity NPC173516
0.9355 High Similarity NPC476860
0.9355 High Similarity NPC476856
0.9355 High Similarity NPC476857
0.9355 High Similarity NPC123088
0.9355 High Similarity NPC476858
0.9346 High Similarity NPC477403
0.9342 High Similarity NPC126723
0.9299 High Similarity NPC471397
0.9295 High Similarity NPC23387
0.929 High Similarity NPC469338
0.929 High Similarity NPC292389
0.9286 High Similarity NPC335761
0.9267 High Similarity NPC196864
0.9267 High Similarity NPC159927
0.9267 High Similarity NPC46551
0.9267 High Similarity NPC469335
0.9267 High Similarity NPC477404
0.9252 High Similarity NPC86935
0.9236 High Similarity NPC472282
0.9236 High Similarity NPC476853
0.9236 High Similarity NPC476850
0.9236 High Similarity NPC476861
0.9231 High Similarity NPC469849
0.9231 High Similarity NPC276551
0.9231 High Similarity NPC470940
0.9226 High Similarity NPC69028
0.9177 High Similarity NPC160651
0.9172 High Similarity NPC470875
0.9167 High Similarity NPC469846
0.9167 High Similarity NPC134254
0.9167 High Similarity NPC39986
0.9167 High Similarity NPC476197
0.9167 High Similarity NPC302369
0.9167 High Similarity NPC477405
0.9161 High Similarity NPC477402
0.9161 High Similarity NPC472653
0.9128 High Similarity NPC262198
0.9119 High Similarity NPC302392
0.9103 High Similarity NPC117986
0.9103 High Similarity NPC149896
0.9103 High Similarity NPC96443
0.9103 High Similarity NPC197596
0.9103 High Similarity NPC263432
0.9103 High Similarity NPC290400
0.9085 High Similarity NPC178932
0.9038 High Similarity NPC191828
0.9032 High Similarity NPC167142
0.9032 High Similarity NPC187149
0.9026 High Similarity NPC469336
0.9026 High Similarity NPC214541
0.9026 High Similarity NPC44675
0.9026 High Similarity NPC264943
0.902 High Similarity NPC75906
0.902 High Similarity NPC476201
0.8993 High Similarity NPC142113
0.8981 High Similarity NPC82851
0.8981 High Similarity NPC18347
0.8981 High Similarity NPC329938
0.8968 High Similarity NPC469485
0.8954 High Similarity NPC18135
0.894 High Similarity NPC221809
0.8938 High Similarity NPC271235
0.891 High Similarity NPC173544
0.891 High Similarity NPC299038
0.891 High Similarity NPC249021
0.891 High Similarity NPC261597
0.8903 High Similarity NPC476262
0.8903 High Similarity NPC281258
0.8896 High Similarity NPC44577
0.8889 High Similarity NPC476122
0.8875 High Similarity NPC472774
0.8875 High Similarity NPC472775
0.8875 High Similarity NPC472651
0.8868 High Similarity NPC271657
0.8861 High Similarity NPC472771
0.8854 High Similarity NPC475967
0.8844 High Similarity NPC476943
0.8839 High Similarity NPC57998
0.882 High Similarity NPC472652
0.8816 High Similarity NPC470941
0.8812 High Similarity NPC475779
0.8805 High Similarity NPC472773
0.8805 High Similarity NPC224394
0.8805 High Similarity NPC663
0.879 High Similarity NPC45101
0.879 High Similarity NPC472772
0.879 High Similarity NPC36655
0.8776 High Similarity NPC310830
0.8774 High Similarity NPC469503
0.8773 High Similarity NPC469848
0.8734 High Similarity NPC307383
0.8718 High Similarity NPC30222
0.8718 High Similarity NPC282445
0.8716 High Similarity NPC220094
0.8688 High Similarity NPC419
0.8667 High Similarity NPC167340
0.8667 High Similarity NPC262386
0.8662 High Similarity NPC35000
0.865 High Similarity NPC470995
0.8642 High Similarity NPC476224
0.8636 High Similarity NPC19747
0.8634 High Similarity NPC470182
0.8627 High Similarity NPC346
0.8625 High Similarity NPC200782
0.8625 High Similarity NPC207978
0.8625 High Similarity NPC471167
0.8625 High Similarity NPC6326
0.8625 High Similarity NPC471166
0.8614 High Similarity NPC478177
0.8598 High Similarity NPC159232
0.8598 High Similarity NPC160818
0.8598 High Similarity NPC169299
0.8589 High Similarity NPC327922
0.858 High Similarity NPC478178
0.8571 High Similarity NPC471168
0.8571 High Similarity NPC250228
0.8562 High Similarity NPC287559
0.8553 High Similarity NPC470741
0.8553 High Similarity NPC223415
0.8544 High Similarity NPC75310
0.8537 High Similarity NPC82602
0.8535 High Similarity NPC268905
0.8526 High Similarity NPC156189
0.8519 High Similarity NPC146991
0.8509 High Similarity NPC472668
0.8509 High Similarity NPC18986
0.8509 High Similarity NPC211777
0.85 High Similarity NPC474932
0.85 High Similarity NPC262872
0.8497 Intermediate Similarity NPC476944
0.8497 Intermediate Similarity NPC137295
0.8494 Intermediate Similarity NPC471437
0.8494 Intermediate Similarity NPC236004
0.8491 Intermediate Similarity NPC204663
0.8487 Intermediate Similarity NPC473152
0.8471 Intermediate Similarity NPC242068
0.8471 Intermediate Similarity NPC247563
0.8471 Intermediate Similarity NPC272590
0.8471 Intermediate Similarity NPC116717
0.8466 Intermediate Similarity NPC121995
0.8462 Intermediate Similarity NPC195325
0.8462 Intermediate Similarity NPC471001
0.8457 Intermediate Similarity NPC198047
0.8457 Intermediate Similarity NPC472669
0.8452 Intermediate Similarity NPC255414
0.8447 Intermediate Similarity NPC333139
0.8438 Intermediate Similarity NPC195131
0.8431 Intermediate Similarity NPC243577
0.8431 Intermediate Similarity NPC267632
0.8428 Intermediate Similarity NPC92979
0.8421 Intermediate Similarity NPC20500
0.8418 Intermediate Similarity NPC475777
0.8415 Intermediate Similarity NPC478179
0.8408 Intermediate Similarity NPC5180
0.8405 Intermediate Similarity NPC56358
0.84 Intermediate Similarity NPC42400
0.8395 Intermediate Similarity NPC188649
0.8393 Intermediate Similarity NPC472665
0.8387 Intermediate Similarity NPC62799
0.8387 Intermediate Similarity NPC471292
0.8385 Intermediate Similarity NPC474611
0.8383 Intermediate Similarity NPC94763
0.8377 Intermediate Similarity NPC199044
0.8377 Intermediate Similarity NPC251865
0.8377 Intermediate Similarity NPC238843
0.8373 Intermediate Similarity NPC285227
0.8366 Intermediate Similarity NPC121158
0.8365 Intermediate Similarity NPC114880
0.8364 Intermediate Similarity NPC296558
0.8363 Intermediate Similarity NPC105395
0.8355 Intermediate Similarity NPC90296
0.8354 Intermediate Similarity NPC291150
0.8354 Intermediate Similarity NPC149945
0.8354 Intermediate Similarity NPC97574
0.8354 Intermediate Similarity NPC93172
0.8344 Intermediate Similarity NPC472654
0.8344 Intermediate Similarity NPC88841
0.8344 Intermediate Similarity NPC329180
0.8344 Intermediate Similarity NPC288602

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC60973 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8447 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.8092 Intermediate Similarity NPD8434 Phase 2
0.8086 Intermediate Similarity NPD5760 Phase 2
0.8086 Intermediate Similarity NPD5761 Phase 2
0.7803 Intermediate Similarity NPD6764 Approved
0.7803 Intermediate Similarity NPD6765 Approved
0.7627 Intermediate Similarity NPD6785 Approved
0.7627 Intermediate Similarity NPD6784 Approved
0.7484 Intermediate Similarity NPD1471 Phase 3
0.747 Intermediate Similarity NPD6599 Discontinued
0.744 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD5494 Approved
0.7384 Intermediate Similarity NPD1247 Approved
0.7368 Intermediate Similarity NPD919 Approved
0.731 Intermediate Similarity NPD7075 Discontinued
0.7289 Intermediate Similarity NPD920 Approved
0.7212 Intermediate Similarity NPD6799 Approved
0.7193 Intermediate Similarity NPD5402 Approved
0.7176 Intermediate Similarity NPD6801 Discontinued
0.7169 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7819 Suspended
0.7134 Intermediate Similarity NPD4628 Phase 3
0.7118 Intermediate Similarity NPD7411 Suspended
0.7111 Intermediate Similarity NPD6559 Discontinued
0.711 Intermediate Similarity NPD3749 Approved
0.7101 Intermediate Similarity NPD3226 Approved
0.7093 Intermediate Similarity NPD3817 Phase 2
0.7083 Intermediate Similarity NPD5403 Approved
0.7079 Intermediate Similarity NPD3751 Discontinued
0.7066 Intermediate Similarity NPD5401 Approved
0.7066 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7043 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD8285 Discontinued
0.6994 Remote Similarity NPD2796 Approved
0.6994 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6983 Remote Similarity NPD7893 Clinical (unspecified phase)
0.697 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6963 Remote Similarity NPD4107 Approved
0.6957 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6954 Remote Similarity NPD3882 Suspended
0.6951 Remote Similarity NPD2346 Discontinued
0.695 Remote Similarity NPD8404 Phase 2
0.6949 Remote Similarity NPD3787 Discontinued
0.6946 Remote Similarity NPD7236 Approved
0.6944 Remote Similarity NPD5844 Phase 1
0.6933 Remote Similarity NPD3748 Approved
0.6928 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6919 Remote Similarity NPD8150 Discontinued
0.691 Remote Similarity NPD3926 Phase 2
0.6889 Remote Similarity NPD7799 Discontinued
0.6879 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6872 Remote Similarity NPD2403 Approved
0.6872 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6867 Remote Similarity NPD1243 Approved
0.6864 Remote Similarity NPD4378 Clinical (unspecified phase)
0.686 Remote Similarity NPD4380 Phase 2
0.6857 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6851 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6848 Remote Similarity NPD8313 Approved
0.6848 Remote Similarity NPD8312 Approved
0.6839 Remote Similarity NPD4482 Phase 3
0.6839 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6824 Remote Similarity NPD6273 Approved
0.6818 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6802 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6793 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6786 Remote Similarity NPD3887 Approved
0.6782 Remote Similarity NPD1934 Approved
0.6778 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6778 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6778 Remote Similarity NPD6166 Phase 2
0.6772 Remote Similarity NPD3266 Approved
0.6772 Remote Similarity NPD3267 Approved
0.6765 Remote Similarity NPD2533 Approved
0.6765 Remote Similarity NPD2532 Approved
0.6765 Remote Similarity NPD2534 Approved
0.676 Remote Similarity NPD6808 Phase 2
0.675 Remote Similarity NPD6832 Phase 2
0.6744 Remote Similarity NPD7239 Suspended
0.674 Remote Similarity NPD7473 Discontinued
0.6727 Remote Similarity NPD2799 Discontinued
0.6726 Remote Similarity NPD3750 Approved
0.6707 Remote Similarity NPD1549 Phase 2
0.6705 Remote Similarity NPD7458 Discontinued
0.6704 Remote Similarity NPD6959 Discontinued
0.6704 Remote Similarity NPD8127 Discontinued
0.6703 Remote Similarity NPD3818 Discontinued
0.6687 Remote Similarity NPD6099 Approved
0.6687 Remote Similarity NPD6100 Approved
0.6687 Remote Similarity NPD1551 Phase 2
0.6686 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6685 Remote Similarity NPD6797 Phase 2
0.6685 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6684 Remote Similarity NPD7435 Discontinued
0.6667 Remote Similarity NPD2313 Discontinued
0.6667 Remote Similarity NPD6232 Discontinued
0.6667 Remote Similarity NPD3268 Approved
0.6667 Remote Similarity NPD2800 Approved
0.6649 Remote Similarity NPD7251 Discontinued
0.6647 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6647 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6646 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6646 Remote Similarity NPD6355 Discontinued
0.6646 Remote Similarity NPD1933 Approved
0.6634 Remote Similarity NPD4111 Phase 1
0.6631 Remote Similarity NPD8407 Phase 2
0.6629 Remote Similarity NPD5890 Approved
0.6629 Remote Similarity NPD5889 Approved
0.6627 Remote Similarity NPD7033 Discontinued
0.6624 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6613 Remote Similarity NPD7808 Phase 3
0.6603 Remote Similarity NPD17 Approved
0.6593 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6587 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6585 Remote Similarity NPD4307 Phase 2
0.6573 Remote Similarity NPD7768 Phase 2
0.6571 Remote Similarity NPD6585 Discontinued
0.657 Remote Similarity NPD7410 Clinical (unspecified phase)
0.657 Remote Similarity NPD7907 Approved
0.6559 Remote Similarity NPD8368 Discontinued
0.6559 Remote Similarity NPD7685 Pre-registration
0.6554 Remote Similarity NPD2801 Approved
0.6553 Remote Similarity NPD4665 Approved
0.6548 Remote Similarity NPD2353 Approved
0.6548 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6548 Remote Similarity NPD5763 Approved
0.6548 Remote Similarity NPD3057 Approved
0.6548 Remote Similarity NPD5762 Approved
0.6548 Remote Similarity NPD2344 Approved
0.6541 Remote Similarity NPD7074 Phase 3
0.6538 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6537 Remote Similarity NPD5980 Discovery
0.6532 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6531 Remote Similarity NPD6779 Approved
0.6531 Remote Similarity NPD6781 Approved
0.6531 Remote Similarity NPD6780 Approved
0.6531 Remote Similarity NPD6782 Approved
0.6531 Remote Similarity NPD6776 Approved
0.6531 Remote Similarity NPD6777 Approved
0.6531 Remote Similarity NPD6778 Approved
0.6524 Remote Similarity NPD8032 Phase 2
0.6517 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6509 Remote Similarity NPD970 Clinical (unspecified phase)
0.6509 Remote Similarity NPD2897 Discontinued
0.6497 Remote Similarity NPD37 Approved
0.6497 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6492 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6488 Remote Similarity NPD2935 Discontinued
0.6486 Remote Similarity NPD7054 Approved
0.6485 Remote Similarity NPD7874 Approved
0.6485 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6485 Remote Similarity NPD7966 Clinical (unspecified phase)
0.648 Remote Similarity NPD4967 Phase 2
0.648 Remote Similarity NPD7058 Phase 2
0.648 Remote Similarity NPD4965 Approved
0.648 Remote Similarity NPD4966 Approved
0.648 Remote Similarity NPD7057 Phase 3
0.6478 Remote Similarity NPD1608 Approved
0.6478 Remote Similarity NPD3972 Approved
0.6465 Remote Similarity NPD2972 Approved
0.6465 Remote Similarity NPD3533 Approved
0.6463 Remote Similarity NPD6798 Discontinued
0.6461 Remote Similarity NPD1465 Phase 2
0.6452 Remote Similarity NPD7472 Approved
0.6447 Remote Similarity NPD4580 Approved
0.6446 Remote Similarity NPD447 Suspended
0.6437 Remote Similarity NPD1512 Approved
0.6433 Remote Similarity NPD7003 Approved
0.6433 Remote Similarity NPD5585 Approved
0.6432 Remote Similarity NPD7696 Phase 3
0.6432 Remote Similarity NPD2163 Approved
0.6432 Remote Similarity NPD7698 Approved
0.6432 Remote Similarity NPD7697 Approved
0.6429 Remote Similarity NPD1510 Phase 2
0.6429 Remote Similarity NPD4308 Phase 3
0.6424 Remote Similarity NPD6233 Phase 2
0.642 Remote Similarity NPD1019 Discontinued
0.642 Remote Similarity NPD2798 Approved
0.6409 Remote Similarity NPD6234 Discontinued
0.6406 Remote Similarity NPD8435 Approved
0.6402 Remote Similarity NPD2968 Approved
0.6402 Remote Similarity NPD2971 Approved
0.6402 Remote Similarity NPD7095 Approved
0.64 Remote Similarity NPD8319 Approved
0.64 Remote Similarity NPD8320 Phase 1
0.64 Remote Similarity NPD7871 Phase 2
0.64 Remote Similarity NPD7870 Phase 2
0.6395 Remote Similarity NPD2354 Approved
0.6395 Remote Similarity NPD2309 Approved
0.6393 Remote Similarity NPD5710 Approved
0.6393 Remote Similarity NPD7229 Phase 3
0.6393 Remote Similarity NPD5711 Approved
0.6391 Remote Similarity NPD2438 Suspended
0.6387 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6378 Remote Similarity NPD2975 Approved
0.6378 Remote Similarity NPD2974 Approved
0.6378 Remote Similarity NPD2973 Approved
0.6369 Remote Similarity NPD7097 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data